Observational studyJournal of diabetes investigation2018
Non-high-density lipoprotein cholesterol is more informative than traditional cholesterol indices in predicting diabetes risk for women with normal glucose tolerance.
Observational study in Journal of diabetes investigation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 12 citations in OpenAlex.
- Lipids as potential mediators linking body mass index to diabetes: evidence from a mediation analysis based on the NAGALA cohort.BMC endocrine disorders · 2024Article
- Predictive performance of lipid parameters in identifying undiagnosed diabetes and prediabetes: a cross-sectional study in eastern China.BMC endocrine disorders · 2022Article
- New perspective on type 2 diabetes, dyslipidemia and non-alcoholic fatty liver disease.Journal of diabetes investigation · 2020Article
- Diagnostic values and appropriate cutoff points of lipid ratios in patients with abnormal glucose tolerance status: a cross-sectional study.Lipids in health and disease · 2019Article
- Impact of 3-year changes in lipid parameters and their ratios on incident type 2 diabetes: Tehran lipid and glucose study.Nutrition & metabolism · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 2 institutions in 2 countries.
Funding
Abstract
AIMS/
introductionLimited data are available regarding the performance of non-high-density lipoprotein cholesterol (non-HDL) in predicting incident diabetes. We aimed to analyze the association between non-HDL and development of diabetes, and to estimate the cut-off point of non-HDL for discriminating incident diabetes in people with normal glucose tolerance. MATERIALS AND
methodsOf 3,653 middle-aged and elderly Chinese with normal glucose tolerance at enrollment, 1,025 men and 1,805 women returned to the 3-year follow up and were involved in the final analysis. Logistic regression analysis was used to test the association between cholesterol indices and incident diabetes, and receiver operating characteristic analyses were used to identify the optimal cut-off of each cholesterol variable for incident diabetes.
resultsNon-HDL was an independent risk factor for diabetes for women, but not for men. In women, a 1-standard deviation increment in non-HDL was associated with a 1.43-fold higher risk of diabetes (95% confidence interval 1.14-1.79; P = 0.002), whereas odds ratios for total cholesterol and low-density lipoprotein cholesterol were 1.33 (95% confidence interval 1.06-1.67; P = 0.015) and 1.30 (95% confidence interval 1.04-1.64; P = 0.024), respectively. The discriminatory power and the optimal cut-off value of non-HDL for incident diabetes increased across body mass index categories. For women with obesity, the threshold of non-HDL for screening of diabetes was estimated as 3.51 mmol/L.
conclusionsNon-HDL had better performance than traditional cholesterol indices in predicting diabetes in women, but not in men. A body mass index-specific threshold value for a non-HDL-controlling target is required in the prevention of type 2 diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.